New Insights into Gamma Delta T Cells (γδ T Cells) in Health and Disease
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Immunology".
Deadline for manuscript submissions: closed (30 April 2023) | Viewed by 268
Special Issue Editors
Interests: immunology; oncology; transplant
Interests: cell biology; molecular investigations; immunology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Gamma delta (γδ) T cells are the prototype of ‘unconventional’ T cells and represent a relatively small subset of T cells in peripheral blood, with functions not restricted to MHC-mediated antigen presentation. As a bridge between innate and adaptive immune systems, γδ T cells participate in various immune responses. γδ T cells have recently gained considerable attention as an attractive tool for cancer adoptive immunotherapy due to their potent antitumor activity and unique role in immunosurveillance. To date, preclinical and clinical studies using γδ T cells for treating a variety of cancers have shown great promise.
The purpose of this Special Issue is to focus on research progress involved in the progression of γδ T cells. Consequently, we warmly invite the community to submit original articles or reviews covering the above mentioned field.
We look forward to your contributions.
Dr. Irma Airoldi
Dr. Serena Meraviglia
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Gd T cells
- immunotherapy
- bisphosphonates
- cancer
- autoimmune disease
